Insider Title Company Date Price Return Shares Value
Shankar Gopi Chief Development Officer Larimar Therapeutics, Inc. (LRMR) 2023-12-07 $3.73 138.5% 5,000 $18,662
Return Profit / (loss) Cost
Total 138.5% $25,839 $18,662